ÂÜÀòÂÒÂ×

Hubert Lam is a seasoned professional in the field of preclinical development and vaccine research, currently serving as Vice President of Preclinical Development at Affini-T Therapeutics since November 2021. Previously, Hubert held senior roles at Genocea, including Senior Director and Director of Preclinical Development, leading significant programs in adoptive cell therapy and cancer immunotherapies. With prior experience at Sanofi Pasteur as Deputy Director of Bacteriology and as a post-doctoral fellow at Harvard Medical School, Hubert has made substantial contributions to vaccine development and infectious disease research. Hubert holds a Ph.D. in Molecular, Cellular and Developmental Biology from Yale University and a B.A. in Biology from Colby College.